Table 1.
Characteristic | 1st quartile (n=28,206) | 2nd quartile (n=24,261) | 3rd quartile (n=27,213) | 4th quartile (n=22,092) | Missing OBCS data (n=34,620) | Complete cases (n=101,772) | Total (n=136,392) |
---|---|---|---|---|---|---|---|
Hospitals | 56 (28.1) | 57 (28.6) | 41 (20.6) | 45 (22.6) | – | – | 199 (100) |
OBCS (%, IQR) | 91.5, 3.6 | 94.5, 0.8 | 96.3, 0.7 | 98.3, 1.2 | – | – | 95.3, 3.4 |
Age (years) | 69.7±13.8 | 69.0±13.7 | 68.6±13.8 | 68.1±13.7 | 68.9±13.9 | 68.9±13.8 | 68.9±13.8 |
Systolic blood pressure (mmHg) | 141.0±27.8 | 141.3±28.3 | 140.8±28.3 | 139.7±27.7 | 139.5±28.9 | 140.7±28.1 | 140.4±28.3 |
Heart rate (bpm) | 81.9±22.4 | 81.4±22.7 | 81.2±22.0 | 80.1±21.2 | 82.0±23.1 | 81.2±22.1 | 81.4±22.4 |
IMD score | 21.8±16.0 | 20.5±16.2 | 20.5±15.7 | 24.5±17.9 | 22.7±141.6 | 21.7±16.5 | 22.0±72.0 |
Female | 9838 (35.0) | 7997 (33.0) | 8778 (32.3) | 7235 (32.8) | 11,512 (33.5) | 33,848 (33.3) | 45,360 (33.4) |
Coronary artery catheterization* | 16,707 (61.8) | 16,189 (70.0) | 18,367 (70.1) | 15,547 (72.7) | 22,483 (70.7) | 66,810 (68.4) | 89,293 (68.9) |
Previous AMI | 7078 (27.1) | 6007 (26.4) | 6812 (25.7) | 5579 (26.0) | 8065 (26.8) | 25,476 (26.3) | 33,541 (26.4) |
Diabetes mellitus | 5614 (20.3) | 4667 (19.7) | 5208 (19.5) | 4087 (19.0) | 6379 (20.1) | 19,576 (19.6) | 25,955 (19.7) |
Hypertension | 13,121 (50.1) | 11,320 (50.5) | 13,482 (51.1) | 10,646 (49.6) | 15,200 (50.5) | 48,569 (50.4) | 63,769 (50.4) |
Chronic renal failure | 1249 (5.0) | 1113 (5.2) | 1409 (5.4) | 920 (4.3) | 1634 (5.6) | 4691 (5.0) | 6325 (5.1) |
Chronic heart failure | 1512 (6.0) | 1249 (5.8) | 1412 (5.4) | 1052 (4.9) | 1633 (5.6) | 5225 (5.5) | 6858 (5.6) |
Aspirin on discharge | 23,371 (96.6) | 20,375 (98.4) | 23,630 (99.1) | 19,535 (99.6) | 17,657 (95.0) | 86,911 (98.4) | 10,456 (97.8) |
Thienopyridine on discharge | 22,232 (93.3) | 19,320 (96.7) | 22,399 (97.4) | 18,658 (98.8) | 9176 (94.7) | 82,609 (96.4) | 91,785 (96.2) |
Beta-blocker on discharge | 19,933 (90.0) | 17,329 (93.9) | 20,291 (95.8) | 17,088 (98.4) | 14,175 (88.1) | 74,641 (94.3) | 88,816 (93.2) |
ACEi on discharge | 20,345 (87.3) | 18,131 (91.8) | 21,451 (94.9) | 18,067 (97.5) | 14,263 (85.6) | 77,994 (92.6) | 92,257 (91.5) |
Statin on discharge | 23,546 (94.7) | 20,477 (97.1) | 23,774 (97.9) | 19,585 (98.9) | 17,427 (93.0) | 87,382 (97.0) | 10,480 (96.4) |
Cardiac rehabilitation on discharge | 21,560 (82.6) | 20,387 (89.2) | 23,675 (92.4) | 19,811 (96.6) | 14,288 (85.2) | 85,433 (89.8) | 99,721 (89.1) |
30-day mortality rate (%, 95% CI) | 2.25 (2.07–2.43) | 2.43 (2.23–2.62) | 1.66 (1.51–1.81) | 1.40 (1.25–1.56) | 3.17 (2.98–3.36) | 1.95 (1.86–2.03) | 2.25 (2.17–2.33) |
6-month mortality rate (%, 95% CI) | 7.93 (7.61–8.25) | 6.81 (6.48–7.13) | 6.59 (6.29–6.89) | 5.53 (5.22–5.83) | 8.50 (8.19–8.80) | 6.78 (6.62–6.93) | 7.20 (7.06–7.34) |
Values are n (%) or mean±SD unless otherwise stated. Missing OBCS data refers to one or more component of the OBCS is missing.
Coronary artery catheterization refers to any patient being referred for any form of coronary angiography including primary PCI if appropriate.
ACEi, angiotensin-converting enzyme inhibitor; AMI, acute myocardial infarction; IMD, index of multiple deprivation; PCI, percutaneous coronary intervention.